2023 Q2 Form 10-Q Financial Statement

#000003490323000044 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $280.7M $273.1M
YoY Change 6.28% 6.34%
Cost Of Revenue $87.99M $87.77M
YoY Change 6.74% 1.15%
Gross Profit $192.7M $185.3M
YoY Change 6.07% 8.99%
Gross Profit Margin 68.65% 67.86%
Selling, General & Admin $11.91M $12.55M
YoY Change -12.43% 1.64%
% of Gross Profit 6.18% 6.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $78.97M $78.64M
YoY Change 6.06% 9.71%
% of Gross Profit 40.99% 42.44%
Operating Expenses $178.9M $179.0M
YoY Change 4.91% 4.78%
Operating Profit $101.8M $95.81M
YoY Change 8.76% 11.43%
Interest Expense $42.88M $39.23M
YoY Change 33.7% 24.24%
% of Operating Profit 42.13% 40.94%
Other Income/Expense, Net
YoY Change
Pretax Income $63.00M $57.73M
YoY Change -2.27% 5.49%
Income Tax
% Of Pretax Income
Net Earnings $60.50M $55.34M
YoY Change -1.91% 6.45%
Net Earnings / Revenue 21.55% 20.26%
Basic Earnings Per Share $0.72 $0.65
Diluted Earnings Per Share $0.72 $0.65
COMMON SHARES
Basic Shares Outstanding 81.52M shares 81.35M shares
Diluted Shares Outstanding 81.21M shares 81.14M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.06M $99.45M
YoY Change -44.46% -37.04%
Cash & Equivalents $98.06M $99.45M
Short-Term Investments
Other Short-Term Assets $242.3M $249.2M
YoY Change 16.16% 10.6%
Inventory
Prepaid Expenses
Receivables $195.7M $200.5M
Other Receivables $9.222M $9.443M
Total Short-Term Assets $545.3M $558.6M
YoY Change -6.31% -3.06%
LONG-TERM ASSETS
Property, Plant & Equipment $7.694B $7.559B
YoY Change 6.91% 7.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $34.94M $143.5M
YoY Change 158.54% 988.25%
Other Assets $4.692M $7.829M
YoY Change -73.93% -61.33%
Total Long-Term Assets $7.734B $7.711B
YoY Change 6.99% 8.72%
TOTAL ASSETS
Total Short-Term Assets $545.3M $558.6M
Total Long-Term Assets $7.734B $7.711B
Total Assets $8.279B $8.269B
YoY Change 6.0% 7.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $187.0M $196.1M
YoY Change -17.49% -16.12%
Accrued Expenses $76.93M $77.44M
YoY Change 7.1% 7.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $383.7M $392.3M
YoY Change -7.12% -6.32%
LONG-TERM LIABILITIES
Long-Term Debt $4.499B $4.457B
YoY Change 9.68% 8.2%
Other Long-Term Liabilities $237.3M $237.3M
YoY Change 13.43% 17.67%
Total Long-Term Liabilities $4.737B $4.694B
YoY Change 9.86% 8.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $383.7M $392.3M
Total Long-Term Liabilities $4.737B $4.694B
Total Liabilities $5.120B $5.087B
YoY Change 8.37% 7.32%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $3.834B $3.830B
YoY Change 1.99% 7.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.901B $2.925B
YoY Change
Total Liabilities & Shareholders Equity $8.279B $8.269B
YoY Change 6.0% 7.84%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $60.50M $55.34M
YoY Change -1.91% 6.45%
Depreciation, Depletion And Amortization $78.97M $78.64M
YoY Change 6.06% 9.71%
Cash From Operating Activities $149.3M $143.0M
YoY Change -5.2% 38.75%
INVESTING ACTIVITIES
Capital Expenditures $103.3M $111.9M
YoY Change -149.29% -231.57%
Acquisitions
YoY Change
Other Investing Activities -$98.00K $11.05M
YoY Change -95.76% -447.91%
Cash From Investing Activities -$103.4M -$100.8M
YoY Change -51.2% 14.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.40M -$31.27M
YoY Change -171.21% 163.87%
NET CHANGE
Cash From Operating Activities 149.3M $143.0M
Cash From Investing Activities -103.4M -$100.8M
Cash From Financing Activities -50.40M -$31.27M
Net Change In Cash -4.522M $10.93M
YoY Change -127.63% 261.2%
FREE CASH FLOW
Cash From Operating Activities $149.3M $143.0M
Capital Expenditures $103.3M $111.9M
Free Cash Flow $45.98M $31.15M
YoY Change -87.47% -83.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei City Area Code
CityAreaCode
301
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
998-8100
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000034903
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-07533
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
FEDERAL REALTY INVESTMENT TRUST
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3916363
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
909 Rose Avenue, Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
North Bethesda
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20852
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81515397 shares
CY2023Q1 frt Operating Real Estate From Consolidated Variable Interest Entities
OperatingRealEstateFromConsolidatedVariableInterestEntities
2002163000 usd
CY2022Q4 frt Operating Real Estate From Consolidated Variable Interest Entities
OperatingRealEstateFromConsolidatedVariableInterestEntities
1997583000 usd
CY2023Q1 us-gaap Rental Properties
RentalProperties
9532332000 usd
CY2022Q4 us-gaap Rental Properties
RentalProperties
9441945000 usd
CY2023Q1 frt Constructioninprogresofconsolidatedvariableieestentity
Constructioninprogresofconsolidatedvariableieestentity
12174000 usd
CY2022Q4 frt Constructioninprogresofconsolidatedvariableieestentity
Constructioninprogresofconsolidatedvariableieestentity
8477000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
664184000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
662554000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
10196516000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
190340000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
90436000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
10104499000 usd
CY2023Q1 frt Accumulated Depreciation And Amortization Consolidated Variable Interest Entities
AccumulatedDepreciationAndAmortizationConsolidatedVariableInterestEntities
376441000 usd
CY2022Q4 frt Accumulated Depreciation And Amortization Consolidated Variable Interest Entities
AccumulatedDepreciationAndAmortizationConsolidatedVariableInterestEntities
362921000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2771150000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2715817000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
7425366000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
7388682000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99449000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85558000 usd
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
200512000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
197648000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
9443000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
9456000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
143464000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
145205000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
88831000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
94569000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
45179000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
45467000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
257050000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
267406000 usd
CY2023Q1 us-gaap Assets
Assets
8269294000 usd
CY2022Q4 us-gaap Assets
Assets
8233991000 usd
CY2023Q1 frt Mortgage Payable From Consolidated Variable Interest Entities
MortgagePayableFromConsolidatedVariableInterestEntities
191193000 usd
CY2022Q4 frt Mortgage Payable From Consolidated Variable Interest Entities
MortgagePayableFromConsolidatedVariableInterestEntities
191827000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
319910000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
320615000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
661391000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
601077000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
3408104000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
3407701000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
196092000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
90263000 usd
CY2023Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
28351000 usd
CY2022Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
28508000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
77442000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
77743000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
67658000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
67660000 usd
CY2023Q1 us-gaap Deferred Credits And Other Liabilities
DeferredCreditsAndOtherLiabilities
237316000 usd
CY2022Q4 us-gaap Deferred Credits And Other Liabilities
DeferredCreditsAndOtherLiabilities
237699000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
5086700000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5021606000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
178353000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
178370000 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81511204 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81511204 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81342959 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81342959 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
820000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
818000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3828930000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3821801000 usd
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1068892000 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1034186000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4546000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5757000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2925226000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2954012000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
79015000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
80003000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3004241000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3034015000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8269294000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8233991000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
272798000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
256507000 usd
CY2023Q1 frt Revenue Mortgage Interest
RevenueMortgageInterest
261000 usd
CY2022Q1 frt Revenue Mortgage Interest
RevenueMortgageInterest
264000 usd
CY2023Q1 us-gaap Revenues
Revenues
273059000 usd
CY2022Q1 us-gaap Revenues
Revenues
256771000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
55205000 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
56211000 usd
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
32566000 usd
CY2022Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
30560000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12545000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12342000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78637000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
71674000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
178953000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
170787000 usd
CY2023Q1 frt Gain On Sale Of Real Estate
GainOnSaleOfRealEstate
1702000 usd
CY2022Q1 frt Gain On Sale Of Real Estate
GainOnSaleOfRealEstate
0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
95808000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
85984000 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
632000 usd
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
120000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
39225000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
31573000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
516000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
197000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
57731000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
54728000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2396000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2744000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
55335000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
51984000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2008000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2010000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
53327000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49974000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81141000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78446000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81141000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78543000 shares
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
56395000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
58644000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54124000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
55556000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3034015000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1668000 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
56063000 usd
CY2023Q1 frt Other Comprehensive Income Loss Attributable To Redeemable Noncontrolling Interest
OtherComprehensiveIncomeLossAttributableToRedeemableNoncontrollingInterest
-125000 usd
CY2023Q1 frt Other Comprehensive Income Loss Net Of Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfPortionAttributableToNoncontrollingInterest
-1211000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.08
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
88033000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2008000 usd
CY2023Q1 frt Redeemable Noncontrolling Interest Decrease From Distributions To Redeemable Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToRedeemableNoncontrollingInterestHolders
1560000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1048000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6251000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
423000 usd
CY2023Q1 frt Share Based Compensation Expense Net Value
ShareBasedCompensationExpenseNetValue
4434000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4645000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3004241000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2663148000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1735000 usd
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
52993000 usd
CY2022Q1 frt Other Comprehensive Income Loss Attributable To Redeemable Noncontrolling Interest
OtherComprehensiveIncomeLossAttributableToRedeemableNoncontrollingInterest
344000 usd
CY2022Q1 frt Other Comprehensive Income Loss Net Of Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfPortionAttributableToNoncontrollingInterest
3572000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.07
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
84196000 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2010000 usd
CY2022Q1 frt Redeemable Noncontrolling Interest Decrease From Distributions To Redeemable Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToRedeemableNoncontrollingInterestHolders
1744000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1759000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
82749000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
502000 usd
CY2022Q1 frt Share Based Compensation Expense Net Value
ShareBasedCompensationExpenseNetValue
4179000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4601000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2714577000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
57731000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
54728000 usd
CY2023Q1 frt Adjustment Depreciation And Amortization
AdjustmentDepreciationAndAmortization
78637000 usd
CY2022Q1 frt Adjustment Depreciation And Amortization
AdjustmentDepreciationAndAmortization
71674000 usd
CY2023Q1 frt Gain On Sale Of Real Estate
GainOnSaleOfRealEstate
1702000 usd
CY2022Q1 frt Gain On Sale Of Real Estate
GainOnSaleOfRealEstate
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
516000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
197000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
2478000 usd
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
4962000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4097000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3820000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1277000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
494000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
466000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
11257000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3563000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4577000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1941000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5419000 usd
CY2023Q1 frt Increase Decrease In Security Deposits And Other Liabilities
IncreaseDecreaseInSecurityDepositsAndOtherLiabilities
3477000 usd
CY2022Q1 frt Increase Decrease In Security Deposits And Other Liabilities
IncreaseDecreaseInSecurityDepositsAndOtherLiabilities
-247000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143007000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103069000 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
35340000 usd
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 usd
CY2023Q1 frt Capital Expenditures Development Redevelopment
CapitalExpendituresDevelopmentRedevelopment
50780000 usd
CY2022Q1 frt Capital Expenditures Development Redevelopment
CapitalExpendituresDevelopmentRedevelopment
66610000 usd
CY2023Q1 frt Capital Expenditures Other
CapitalExpendituresOther
25737000 usd
CY2022Q1 frt Capital Expenditures Other
CapitalExpendituresOther
18409000 usd
CY2023Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
12626000 usd
CY2022Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
874000 usd
CY2023Q1 us-gaap Proceeds From Distributions Received From Real Estate Partnerships
ProceedsFromDistributionsReceivedFromRealEstatePartnerships
2174000 usd
CY2022Q1 us-gaap Proceeds From Distributions Received From Real Estate Partnerships
ProceedsFromDistributionsReceivedFromRealEstatePartnerships
517000 usd
CY2023Q1 us-gaap Increase Decrease In Lease Acquisition Costs
IncreaseDecreaseInLeaseAcquisitionCosts
3754000 usd
CY2022Q1 us-gaap Increase Decrease In Lease Acquisition Costs
IncreaseDecreaseInLeaseAcquisitionCosts
4577000 usd
CY2023Q1 frt Issuance And Repayments Of Mortgage And Other Notes Receivable Net
IssuanceAndRepaymentsOfMortgageAndOtherNotesReceivableNet
0 usd
CY2022Q1 frt Issuance And Repayments Of Mortgage And Other Notes Receivable Net
IssuanceAndRepaymentsOfMortgageAndOtherNotesReceivableNet
-11000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100811000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88194000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
60000000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
819000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
869000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6245000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
82819000 usd
CY2023Q1 frt Dividends Paid To Common And Preferred Shareholders
DividendsPaidToCommonAndPreferredShareholders
89431000 usd
CY2022Q1 frt Dividends Paid To Common And Preferred Shareholders
DividendsPaidToCommonAndPreferredShareholders
85684000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4645000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4601000 usd
CY2023Q1 frt Paymentsofdividendsandredemptionsminorityinterest
Paymentsofdividendsandredemptionsminorityinterest
2616000 usd
CY2022Q1 frt Paymentsofdividendsandredemptionsminorityinterest
Paymentsofdividendsandredemptionsminorityinterest
3514000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31266000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11849000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10930000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3026000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96348000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175163000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107278000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178189000 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
BUSINESS AND ORGANIZATION<div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal Realty Investment Trust (the "Parent Company" and the “Trust”) is an equity real estate investment trust (“REIT”). Federal Realty OP LP (the "Operating Partnership") is the entity through which the Parent Company conducts substantially all of its operations and owns all of its assets. The Parent Company owns 100% of the limited liability company interests of, is sole member of and exercises exclusive control over Federal Realty GP LLC ("the General Partner"), which in turn, is the sole general partner of the Operating Partnership. The Parent Company specializes in the ownership, management, and redevelopment of retail and mixed-use properties through the Operating Partnership, and has no other substantial assets or liabilities other than through its investment in the Operating Partnership. Our properties are located primarily in communities where we believe retail demand exceeds supply, in strategically selected metropolitan markets in the Mid-Atlantic and Northeast regions of the United States, California, and South Florida. As of March 31, 2023, we owned or had a majority interest in community and neighborhood shopping centers and mixed-use properties which are operated as 102 predominantly retail real estate projects.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a manner intended to enable the Trust to qualify as a REIT for federal income tax purposes. A REIT that distributes at least 90% of its taxable income to its shareholders each year and meets certain other conditions is not taxed on that portion of its taxable income which is distributed to its shareholders. Therefore, federal income taxes on our taxable income have been and are generally expected to be immaterial. We are obligated to pay state taxes, generally consisting of franchise or gross receipts taxes in certain states. Such state taxes also have not been material.</span></div>
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
102 project
CY2023Q1 frt Minimum Percentage Of Taxable Income Distributed To Shareholders
MinimumPercentageOfTaxableIncomeDistributedToShareholders
0.90
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, referred to as “GAAP,” requires management to make estimates and assumptions that in certain circumstances affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management’s best judgment, after considering past, current and expected events and economic conditions. Actual results could differ from these estimates.</span></div>
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
44606000 usd
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
36188000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
5381000 usd
CY2022Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
4615000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
39225000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
31573000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
37136000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
30436000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
CY2023Q1 frt Redemptionofdown Rei Toperatingpartnershipunitsforcommonshares
RedemptionofdownREIToperatingpartnershipunitsforcommonshares
668000 usd
CY2022Q1 frt Redemptionofdown Rei Toperatingpartnershipunitsforcommonshares
RedemptionofdownREIToperatingpartnershipunitsforcommonshares
977000 usd
CY2023Q1 frt Dividends Reinvested In Noncash Financing Transaction
DividendsReinvestedInNoncashFinancingTransaction
429000 usd
CY2022Q1 frt Dividends Reinvested In Noncash Financing Transaction
DividendsReinvestedInNoncashFinancingTransaction
432000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99449000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85558000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7829000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10790000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107278000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96348000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.080
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.080
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
4900000 usd
CY2023Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
-400000 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
300000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.070
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.070
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4434000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4179000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
337000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
359000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4097000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3820000 usd
CY2022Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
300000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
57731000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
54728000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2008000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2010000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2396000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2744000 usd
CY2023Q1 frt Earnings Allocated To Unvested Shares
EarningsAllocatedToUnvestedShares
327000 usd
CY2022Q1 frt Earnings Allocated To Unvested Shares
EarningsAllocatedToUnvestedShares
307000 usd
CY2023Q1 frt Net Income Available For Common Shareholders Basic And Diluted
NetIncomeAvailableForCommonShareholdersBasicAndDiluted
53000000 usd
CY2022Q1 frt Net Income Available For Common Shareholders Basic And Diluted
NetIncomeAvailableForCommonShareholdersBasicAndDiluted
49667000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81141000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78446000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
97000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81141000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78543000 shares
CY2023Q1 frt Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
0.65
CY2022Q1 frt Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
0.63

Files In Submission

Name View Source Status
frt-20230331_cal.xml Edgar Link unprocessable
frt-20230331_def.xml Edgar Link unprocessable
0000034903-23-000044-index-headers.html Edgar Link pending
0000034903-23-000044-index.html Edgar Link pending
0000034903-23-000044.txt Edgar Link pending
0000034903-23-000044-xbrl.zip Edgar Link pending
bylawsheader.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
frt-03312023xex311.htm Edgar Link pending
frt-03312023xex312.htm Edgar Link pending
frt-03312023xex313.htm Edgar Link pending
frt-03312023xex314.htm Edgar Link pending
frt-03312023xex321.htm Edgar Link pending
frt-03312023xex322.htm Edgar Link pending
frt-03312023xex323.htm Edgar Link pending
frt-03312023xex324.htm Edgar Link pending
frt-20230331.htm Edgar Link pending
frt-20230331.xsd Edgar Link pending
frt-3312023ex31.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
frt-20230331_lab.xml Edgar Link unprocessable
frt-20230331_pre.xml Edgar Link unprocessable
frt-20230331_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending